's third-quarter performance forecast is being disclosed, and the pharmaceutical sector is gradually leading the rise in the overall market "small fight". According to securities sources, the pharmaceutical and biological sector has increased by more than 2% during the session, and many stocks have hit the daily limit during the session. On October 18, Weikang Pharmaceutical hit the daily limit during the session, and many companies followed suit and touched the daily limit. On October 20, the biopharmaceutical sector once again rose, and many other companies such as Huasen Pharmaceutical , Sailong Pharmaceutical, and Shuangcheng Pharmaceutical collectively hit the daily limit.
The pharmaceutical industry is seen by the industry to regain "confidence" and continue to expand investment opportunities. In the previous period, the decline of the pharmaceutical sector reached about 30%. After October, the market performance of many companies has significantly "flipped" and began to rise. Industry insiders have in-depth analysis that relevant companies' confidence in certainty in growth is gradually recovering, and there will be room for further improvement in targets related to COVID-19 vaccine , blood products, and medical devices. Overall, pharmaceuticals and biology have long-term investment value.
However, in addition to seeing the growth space of the pharmaceutical industry, we must also pay special attention to the wastewater treatment issues that must be paid attention to in the development of pharmaceuticals. At present, the broad consensus reached by the industry is that pharmaceutical wastewater is one of the more difficult industrial wastewater to treat. Its pollutant concentration is high, its composition is complex and its volatility is strong. Some people even believe that changes in the production of pharmaceutical companies, small scale and low technology will affect the results of the treatment of pharmaceutical wastewater to meet standards, and some may be stopped due to environmental protection issues.
Why can't the field of pharmaceutical wastewater treatment be regarded as another trend in the environmental protection industry's revenue increase?
Compared with other industrial wastewater treatment fields, pharmaceutical wastewater treatment is more professional and rigorous. Faced with the need for difficult wastewater treatment in the pharmaceutical industry, the application scope of membrane technology is expanding. Data shows that although the application of membrane technology in related fields of the pharmaceutical industry is relatively low, its growth rate is quite considerable. Judging from the nanofiltration membrane technology alone, its annual compound growth rate reached nearly 20% a few years ago. The benefits of membrane technology innovation and research and development to accelerate the development of high-difficulty wastewater treatment cannot be ignored. Moreover, "green pharmaceuticals" have become the key to pharmaceutical companies' implementation of dual-carbon goals, and the "fault tolerance" in the pharmaceutical wastewater field will continue to decrease. In this way, the field of pharmaceutical wastewater treatment is indeed highly developable.
In April this year, Jiarong Technology successfully completed its listing work. The company is a comprehensive solution provider focusing on high-difficulty and high-concentration wastewater treatment. Pharmaceutical wastewater is an important area of its "professional counterpart". As the news came to the scene, high-energy environment also officially advanced into the field of pharmaceutical wastewater treatment in June this year, and successfully signed the third phase high fluorine wastewater treatment system and the fourth phase high CO bacterial slag wastewater anaerobic treatment system project contract...
finds the pain in the pharmaceutical industry, and the field of pharmaceutical wastewater treatment is expected to become another hot spot for the environmental protection industry to increase revenue!
Statement: The purpose of this website publishing this information is to spread more information and has nothing to do with the position of this website. And solemnly remind all readers that the stock market is risky and investment should be cautious. This article is not used as a reference or basis for any investment.
